Comparison of the efficacy and safety profiles of generic and branded leuprorelin acetate microspheres in patients with prostate cancer

• DOI: 10.3892/ol.2024.14452
• Publication Date: 2024-05-14T11:08:35Z
• Authors: Zhien Zhou; Yi Zhou; Weigang Yan; Tianrui Feng; Zhen Liang
• Keywords: Leuprorelin

Leuprorelin acetate microspheres, a common gonadotropin-releasing hormone agonist, have certain clinical benefits for prostate cancer (PCa). The present study aimed to compare the efficacy and safety of generic branded leuprorelin microspheres in patients with PCa. retrospective, observational included 116 PCa who received (Boennuokang